Company Search:
Advanced Search
Sponsored Links
Adma Biologics Inc Company Snapshot
Adma Biologics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Adma Biologics Inc with three other companies in this sector in the United States: Curis, Inc. (2015 sales of $7.88 million of which 100% was Therapeutic Drug Dev), Champions Oncology Inc ($8.86 million ), and BioTime, Inc. ($7.04 million of which 100% was Synthetic Solutions).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Adma Biologics Inc
  Stock Performance Chart for Adma Biologics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 5.06
(Figures in U.S. Dollars)
1 Week -2.1%   13 Weeks 12.4%  
4 Weeks -19.0%   52 Weeks -16.9%  
Adma Biologics Inc Key Data:
  Ticker: ADMA Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 7,177,633
(Year Ending Jan 2016).
Employees: 72
  Currency: U.S. Dollars Market Cap: 65,206,909
  Fiscal Yr Ends: December Shares Outstanding: 12,886,741
  Share Type: Common Closely Held Shares: 725,615
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.